Table 3.
Level of PrUs risk | Overall Braden scores (n = 318) | Braden scores among patients had MDRPrUs (n = 121) | Braden scores among patients free of MDRPrUs (n = 197) |
---|---|---|---|
≤9 (pevere risk) | 81 (25.5%) | 56 (46.3%) | 25 (12.7%) |
10–12 (high risk) | 51 (16.0%) | 24 (19.8%) | 27 (13.7%) |
13–14 (moderate risk) | 49 (15.4%) | 13 (10.7%) | 36 (18.3%) |
15–18 (mild risk) | 137 (43.1%) | 28 (23.1%) | 109 (55.3%) |